KAPA today
$0.49+$0.03 (+7.33%)close Nov 6, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns up above $1.91
Key levels
Resistance$1.70
Resistance$1.51
Support$0.42
Latest news & SEC filings
NewsKairos Pharma receives 2026 Biotech Breakthrough Award
DealKairos Pharma revises credit facility terms with Helena
All KAPA news →About Kairos Pharma
Kairos Pharma is a clinical-stage biopharmaceutical company developing antibody and small-molecule therapeutics for several tumor types, including malignancies of the prostate, lungs, breast, and brain. Its pipeline focuses on overcoming immune suppression and drug resistance. The company operates through its subsidiary Enviro Therapeutics and licenses technology from Cedars-Sinai Medical Center.
Based on the company's 10-K filed Mar 31, 2026.
NYSE · Healthcare
Kairos Pharma, LTD. (KAPA)
What Is the Price Target for KAPA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is KAPA a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KAPA.
Start Free Trial →Is KAPA Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$0.50
0
Moat Score
NONE
2/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with KAPA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KAPA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-30.43%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for KAPA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KAPA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:39:08 | $0.49 | 1,000 | $$488 | SELL |
| 20:28:34 | $0.48 | 5,000 | $$2K | SELL |
| 19:42:01 | $0.48 | 1,003 | $$485 | SELL |
| 17:46:18 | $0.48 | 3,000 | $$1K | SELL |
| 17:46:04 | $0.49 | 1,500 | $$730 | MIDPOINT |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Kairos Pharma, LTD. (KAPA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KAPA — frequently asked questions
What is KAPA stock price today?
Kairos Pharma, LTD. (KAPA) is at $0.49, up 7.33% (+$0.03) at the Nov 6, 2026 close.
Why is KAPA stock moving today?
Latest KAPA news — Nov 7, 2026: Kairos Pharma receives 2026 Biotech Breakthrough Award · Nov 5, 2026: Kairos Pharma revises credit facility terms with Helena
What do analysts rate KAPA?
Analyst ratings for KAPA: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
Did KAPA beat earnings?
KAPA last reported on Aug 12, 2026: EPS -$0.42 vs -$0.56 expected — a beat of 25.0%.
What are KAPA support and resistance levels?
Support: $0.42. Resistance: $1.51, $1.70, $1.82.
What are insiders doing with KAPA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on KAPA?
Nov 7, 2026: Kairos Pharma receives 2026 Biotech Breakthrough Award · Nov 5, 2026: Kairos Pharma revises credit facility terms with Helena